Inventor
KAKKIS EMIL D
US37 patents
⚠️ This page may combine multiple inventors who share the name “KAKKIS EMIL D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOMARIN PHARM INC
16 patentsUS7442372B2Oct 28, 2008
Delivery of therapeutic compounds to the brain and other tissues
BIOMARIN PHARM INC109 citations99
US7534595B2May 19, 2009
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
BIOMARIN PHARM INC79 citations96
US7537923B2May 26, 2009
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
BIOMARIN PHARM INC49 citations95
US7531341B1May 12, 2009
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
BIOMARIN PHARM INC87 citations95
US7560263B2Jul 14, 2009
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
BIOMARIN PHARM INC81 citations94
US6569661B1May 27, 2003
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
BIOMARIN PHARM INC63 citations93
US9993481B2Jun 12, 2018
Methods and compositions for the treatment of metabolic disorders
BIOMARIN PHARM INC11 citations92
US7566714B2Jul 28, 2009
Methods and compositions for the treatment of metabolic disorders
BIOMARIN PHARM INC15 citations92
US7354576B2Apr 8, 2008
Methods of treating diseases caused by deficiencies of recombinant α-L-iduronidase
BIOMARIN PHARM INC20 citations92
US7790433B2Sep 7, 2010
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
BIOMARIN PHARM INC32 citations91
US8377884B2Feb 19, 2013
Variants of C-type natriuretic peptides
BIOMARIN PHARM INC27 citations88
US9572870B2Feb 21, 2017
Delivery of therapeutic compounds to the brain and other tissues
BIOMARIN PHARM INC6 citations84
US10221408B2Mar 5, 2019
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
BIOMARIN PHARM INC3 citations69
US7601717B2Oct 13, 2009
Pterin analogs
BIOMARIN PHARM INC2 citations63
US11040088B2Jun 22, 2021
Delivery of therapeutic compounds to the brain and other tissues
BIOMARIN PHARM INC0 citations62
US11505790B2Nov 22, 2022
Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof
BIOMARIN PHARM INC1 citations58
ULTRAGENYX PHARMACEUTICAL INC
10 patentsUS11771748B2Oct 3, 2023
Methods for treating tumor-induced osteomalacia
ULTRAGENYX PHARMACEUTICAL INC1 citations70
US11202822B2Dec 21, 2021
Methods for treating hypophosphatemic disorders
ULTRAGENYX PHARMACEUTICAL INC2 citations70
US10639360B2May 5, 2020
Methods for treating hypophosphatemic disorders
ULTRAGENYX PHARMACEUTICAL INC3 citations70
US11332438B2May 17, 2022
Creatine prodrugs, compositions and methods of use thereof
ULTRAGENYX PHARMACEUTICAL INC2 citations67
US12358976B2Jul 15, 2025
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
ULTRAGENYX PHARMACEUTICAL INC0 citations60
US9687532B2Jun 27, 2017
Sialylated glycoprotein compositons and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US9457068B2Oct 4, 2016
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US9457067B2Oct 4, 2016
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US11753369B2Sep 12, 2023
Creatine prodrugs, compositions and methods of use thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations56
US9937243B2Apr 10, 2018
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC0 citations48
KAKKIS EMIL D
5 patentsUS9089566B2Jul 28, 2015
Delivery of therapeutic compounds to the brain and other tissues
KAKKIS EMIL D11 citations92
US9044473B2Jun 2, 2015
Delivery of therapeutic compounds to the brain and other tissues
KAKKIS EMIL D14 citations92
US8324210B2Dec 4, 2012
Pterin analogs
KAKKIS EMIL D2 citations62
US7041487B2May 9, 2006
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
KAKKIS EMIL D2 citations58
US7883707B2Feb 8, 2011
Induction of antigen specific immunnologic tolerance
KAKKIS EMIL D3 citations56
HARBOR UCLA RES & EDUCATION
2 patentsUS6585971B1Jul 1, 2003
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating disease caused by deficiencies thereof
HARBOR UCLA RES & EDUCATION30 citations92
US6426208B1Jul 30, 2002
Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
HARBOR UCLA RES & EDUCATION42 citations92